That's Not GoodWe assign a fundamental rating of 2 out of 10 to HUGE. HUGE was compared to 251 industry peers in the Pharmaceuticals industry. HUGE has a bad profitability rating. Also its financial health evaluation is rather negative. HUGE is valued expensive and it does not seem to be growing.
https://www.chartmill.com/stock/quote/HUGE/fundamental-analysis